By. Katja Weisel, MD Date: October 25. 2023 In the world of multiple myeloma research, Dr. Katja Weisel, MD, stands at the forefront of groundbreaking clinical trials. Her work on the GMMG-CONCEPT trial, involving Isatuximab combination therapy, has unveiled a pivotal shift in the treatment landscape for high-risk multiple myeloma patients.Advertisement Single Between Content Advertisement … Continue reading Sarclisa Phase 2 GMMG-CONCEPT Carfilzomib, Lenalidomide, and Dexamethasone